tenk.fyi

Spyre Therapeutics, Inc.

SYRENasdaq· Pharmaceutical Preparations

Price History

Revenue

$0

Net Income

-$155.2M

25.4% YoY

EPS

-

Cash

$85.7M

4.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro